188 related articles for article (PubMed ID: 33414055)
41. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
Mimae T; Tsuta K; Kondo T; Nitta H; Grogan TM; Okada M; Asamura H; Tsuda H
Ann Oncol; 2012 Dec; 23(12):3129-3137. PubMed ID: 22700994
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.
Girard N; Basse C; Schrock A; Ramkissoon S; Killian K; Ross JS
Oncologist; 2022 Nov; 27(11):919-929. PubMed ID: 35749302
[TBL] [Abstract][Full Text] [Related]
43. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
[TBL] [Abstract][Full Text] [Related]
45. [Therapy-relevant mutations of receptor tyrosine kinases in malignant thymomas and thymic carcinomas: a therapeutic perspective].
Ströbel P; Knop S; Einsele H; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 2007; 91():177-86. PubMed ID: 18314613
[TBL] [Abstract][Full Text] [Related]
46. Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study.
Ströbel P; Zettl A; Shilo K; Chuang WY; Nicholson AG; Matsuno Y; Gal A; Laeng RH; Engel P; Capella C; Marino M; Chan JK; Rosenwald A; Travis W; Franks TJ; Ellenberger D; Schaefer IM; Marx A
Genes Chromosomes Cancer; 2014 Sep; 53(9):738-49. PubMed ID: 24764238
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant therapy in stage II thymic carcinoma.
Song Z; Zhang Y
J Cancer Res Clin Oncol; 2014 Feb; 140(2):349-52. PubMed ID: 24305755
[TBL] [Abstract][Full Text] [Related]
48. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
49. Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.
Asao T; Fujiwara Y; Sunami K; Kitahara S; Goto Y; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Ichikawa H; Kohno T; Tsuta K; Watanabe S; Takahashi K; Ohe Y
Lung Cancer; 2016 Mar; 93():77-81. PubMed ID: 26898618
[TBL] [Abstract][Full Text] [Related]
50. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
51. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database.
Ruffini E; Detterbeck F; Van Raemdonck D; Rocco G; Thomas P; Weder W; Brunelli A; Guerrera F; Keshavjee S; Altorki N; Schützner J; Arame A; Spaggiari L; Lim E; Toker A; Venuta F;
J Thorac Oncol; 2014 Apr; 9(4):541-8. PubMed ID: 24736078
[TBL] [Abstract][Full Text] [Related]
52. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?
Viti A; Bertolaccini L; Terzi A
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1054-8. PubMed ID: 25193970
[TBL] [Abstract][Full Text] [Related]
53. LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑
Wang J; Huang H; Zhang X; Ma H
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907842
[TBL] [Abstract][Full Text] [Related]
54. Comparison of patterns of relapse in thymic carcinoma and thymoma.
Huang J; Rizk NP; Travis WD; Riely GJ; Park BJ; Bains MS; Dycoco J; Flores RM; Downey RJ; Rusch VW
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):26-31. PubMed ID: 19577051
[TBL] [Abstract][Full Text] [Related]
55. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
Suster D; Pihan G; Mackinnon AC; Suster S
Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
[TBL] [Abstract][Full Text] [Related]
56. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma.
Jackson MW; Palma DA; Camidge DR; Jones BL; Robin TP; Sher DJ; Koshy M; Kavanagh BD; Gaspar LE; Rusthoven CG
J Thorac Oncol; 2017 Apr; 12(4):734-744. PubMed ID: 28126540
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathologic assessment of primary thymic carcinoma based on eighteen cases].
Saito R; Kondo T; Matsumura Y; Ohura H; Hirose M; Sugita M; Sado T; Fujimura S
Kyobu Geka; 1996 Sep; 49(10):797-801. PubMed ID: 8828321
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of DNA flow cytometry in thymomas and thymic carcinomas.
Sauter ER; Sardi A; Hollier LH; Cooper ES; Bolton JS
South Med J; 1990 Jun; 83(6):656-9. PubMed ID: 2356499
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.
Sakakura N; Tateyama H; Nakamura S; Taniguchi T; Usami N; Ishikawa Y; Kawaguchi K; Yokoi K
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):89-95. PubMed ID: 23229995
[TBL] [Abstract][Full Text] [Related]
60. C-KIT mutation in thymic carcinomas.
Terzi N; Yilmaz I; Batur S; Yegen G; Yol C; Arikan E; Oz A
Pol J Pathol; 2020; 71(2):120-126. PubMed ID: 32729302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
